In fact, our previous studies, along with the current findings, demonstrate that genetic ablation or pharmacological inhibition of MT1-MMP confers protection against multiple age-associated disorders, including cognitive decline, obesity, and diabetes, without adverse effects15–17. The gene discussed is MMP14; the disease is obesity due to melanocortin 4 receptor deficiency.